Mrs Whitney Cabral

Since 2018 Whitney has been driving clinical trials into successful fruition. Her leadership of the CardioSeq clinical trial (2023-2025) cultivated wider use of comprehensive genetic testing in the cardiology clinic at Henry Ford Health (HFH). As the operational leader for the Center for Individualized and Genomic Medicine Research at HFH, and alongside its directors, Drs. David Lanfear and Keoki Williams, she continues to craft pragmatic, real-world genetic research studies as well as various projects.